Non diabetic chronic kidney disease

1 paper

Humans1

Trial sponsors

Bayer
Company1 trialPhase 31,584 people
VA Office of Research and Development
1 trialPhase 252 people

Latest

1 in 12 months

Kidney3607 h

Validation of the Klinrisk CKD Progression Model in the Dapagliflozin and Prevention of Adverse Outcomes in CKD (DAPA-CKD) Population

Cohort study of 4,304 peopleChronic kidney disease